AR060362A1 - Agente para prevenir / tratar el cancer - Google Patents
Agente para prevenir / tratar el cancerInfo
- Publication number
- AR060362A1 AR060362A1 ARP070101453A ARP070101453A AR060362A1 AR 060362 A1 AR060362 A1 AR 060362A1 AR P070101453 A ARP070101453 A AR P070101453A AR P070101453 A ARP070101453 A AR P070101453A AR 060362 A1 AR060362 A1 AR 060362A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- prevent
- treat cancer
- seq
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un anticuerpo monoclonal humano contra una proteína que comprende la misma o sustancialmente la misma secuencia de aminoácidos que la secuencia de aminoácidos representada por la SEC ID N°:1 o SEC ID N°: 3, su péptido parcial o una sal del mismo, es util como agente para prevenir/tratar el cáncer, etc., un inductor de apoptosis de células cancerosas, un inhibidor del crecimiento de células cancerosas, un agente citotoxico contra células cancerosas a través de un mecanismo de defensa del huésped mediado por la region FC de un anticuerpo y demás.
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009117237/10A RU2009117237A (ru) | 2006-10-06 | 2007-10-04 | Средство для профилактики/лечения рака |
BRPI0717024-6A2A BRPI0717024A2 (pt) | 2006-10-06 | 2007-10-04 | Anticorpo, célula de hibridoma, agente de diagnótico, medicamento, métodos para prevenir/tratar câncer, para induzir apoptose células cancerosas , para inibir crescimento de células cancerosas e para destruir células cancerosas, uso de um anicorpo monoclonal e agente para prevenir ou tratar câncer de mama. |
JP2008538759A JPWO2008044754A1 (ja) | 2006-10-06 | 2007-10-04 | 癌の予防・治療剤 |
PCT/JP2007/069908 WO2008044754A1 (fr) | 2006-10-06 | 2007-10-04 | Agent prophylactique ou thérapeutique pour le cancer |
KR1020097009036A KR20090078339A (ko) | 2006-10-06 | 2007-10-04 | 암의 예방·치료제 |
EP07829644A EP2067791A4 (en) | 2006-10-06 | 2007-10-04 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER |
AU2007307536A AU2007307536A1 (en) | 2006-10-06 | 2007-10-04 | Agent for preventing/treating cancer |
CNA2007800371476A CN101541834A (zh) | 2006-10-06 | 2007-10-04 | 癌症的预防和/或治疗剂 |
PE2007001348A PE20081456A1 (es) | 2006-10-06 | 2007-10-04 | Anticuerpo monoclonal contra nectina 2 |
CA002666249A CA2666249A1 (en) | 2006-10-06 | 2007-10-04 | Agent for preventing/treating cancer |
US12/444,382 US20100008928A1 (en) | 2006-10-06 | 2007-10-04 | Agent for preventing/treating cancer |
MX2009003126A MX2009003126A (es) | 2006-10-06 | 2007-10-04 | Agente para prevenir/tratar el cancer. |
CL200702879A CL2007002879A1 (es) | 2007-04-04 | 2007-10-05 | Anticuerpo monoclonal contra nectina-2; celula de hibridoma que lo produce; composicion farmaceutica que lo comprende; y su uso para tratar cancer. |
IL197389A IL197389A0 (en) | 2006-10-06 | 2009-03-03 | Prophylactic or therapeutic agent for cancer |
TN2009000090A TN2009000090A1 (en) | 2007-04-04 | 2009-03-16 | Prophylactic or therapeutic agent for canger |
CR10676A CR10676A (es) | 2006-10-06 | 2009-03-20 | Agente para prevenir/ tratar el cancer |
EC2009009276A ECSP099276A (es) | 2006-10-06 | 2009-04-23 | Agente para prevenir/tratar el cancer |
MA31823A MA30816B1 (fr) | 2006-10-06 | 2009-04-27 | Agent prophylactique ou therapeutique pour le cancer |
CO09044621A CO6190538A2 (es) | 2006-10-06 | 2009-05-04 | Agente para prevenir/tratar el cancer |
NO20091783A NO20091783L (no) | 2006-10-06 | 2009-05-05 | Middel for a forebygge/behandle kreft |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005295146 | 2005-10-07 | ||
PCT/JP2006/320429 WO2007043635A1 (ja) | 2005-10-07 | 2006-10-06 | 癌の予防・治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060362A1 true AR060362A1 (es) | 2008-06-11 |
Family
ID=37942856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101453A AR060362A1 (es) | 2005-10-07 | 2007-04-04 | Agente para prevenir / tratar el cancer |
Country Status (9)
Country | Link |
---|---|
US (1) | US20090142346A1 (es) |
EP (1) | EP1932857A1 (es) |
JP (1) | JPWO2007043635A1 (es) |
AR (1) | AR060362A1 (es) |
CA (1) | CA2639119A1 (es) |
CL (1) | CL2007000974A1 (es) |
PE (1) | PE20080909A1 (es) |
TW (1) | TW200840825A (es) |
WO (1) | WO2007043635A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2663334A4 (en) * | 2011-01-10 | 2016-01-13 | Univ Emory | ANTIBODIES AGAINST INFLUENZA |
JP6656677B2 (ja) * | 2016-09-23 | 2020-03-04 | ティーエフケイ株式会社 | 化合物又はその塩、抗炎症剤、肺がんに対する抗がん剤、化合物又はその塩の製造方法、炎症性疾患の治療方法及び肺がんの治療方法 |
EP3548071A4 (en) | 2016-11-30 | 2020-07-15 | OncoMed Pharmaceuticals, Inc. | METHOD FOR TREATING CANCER WITH TIGIT-BINDING ACTIVE SUBSTANCES |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129685A1 (en) * | 1998-10-28 | 2003-07-10 | Jian Ni | 12 human secreted proteins |
AU1305302A (en) * | 2000-10-05 | 2002-04-15 | Immunex Corp | Nectin polypeptides, polynucleotides, methods of making and use thereof |
EP1733743A4 (en) * | 2004-04-09 | 2007-06-27 | Takeda Pharmaceutical | PREVENTIVE / REMEDY AGAINST CANCER |
-
2006
- 2006-10-06 CA CA002639119A patent/CA2639119A1/en not_active Abandoned
- 2006-10-06 JP JP2007539992A patent/JPWO2007043635A1/ja not_active Withdrawn
- 2006-10-06 WO PCT/JP2006/320429 patent/WO2007043635A1/ja active Application Filing
- 2006-10-06 EP EP06811717A patent/EP1932857A1/en not_active Withdrawn
- 2006-10-06 US US11/992,966 patent/US20090142346A1/en not_active Abandoned
-
2007
- 2007-04-04 AR ARP070101453A patent/AR060362A1/es unknown
- 2007-04-04 TW TW096111984A patent/TW200840825A/zh unknown
- 2007-04-05 CL CL200700974A patent/CL2007000974A1/es unknown
- 2007-04-11 PE PE2007000443A patent/PE20080909A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1932857A1 (en) | 2008-06-18 |
US20090142346A1 (en) | 2009-06-04 |
JPWO2007043635A1 (ja) | 2009-04-16 |
CA2639119A1 (en) | 2007-04-19 |
CL2007000974A1 (es) | 2008-05-02 |
TW200840825A (en) | 2008-10-16 |
PE20080909A1 (es) | 2008-08-28 |
WO2007043635A1 (ja) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR063153A1 (es) | Anticuerpo monoclonal para prevenir/tratar el cancer | |
ES2606173T3 (es) | Composición farmacéutica para el tratamiento y/o la prevención del cáncer | |
ES2675375T3 (es) | Anticuerpos monoclonales contra claudina 18 para el tratamiento del cáncer | |
ES2531083T3 (es) | Formulaciones estables de polipéptidos y usos de las mismas | |
RU2008136324A (ru) | Желудочно-кишечный пролиферативный фактор и его применения | |
PE20110310A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas | |
MX2010002716A (es) | Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago. | |
CL2012000063A1 (es) | Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07). | |
MX2011010908A (es) | Anticuerpos anti-tnf-alfa y sus usos. | |
AR066338A1 (es) | Proteinas toxinas activas contra hemipteros y coleopteros de bacillus thuringiensis | |
CO6180466A2 (es) | Composiciones y metodos para diagnosticar y tratar cancer | |
NO20063026L (no) | Antistoffer | |
AR077096A1 (es) | Toxinas cry insecticidas dig-11 de bacillus thuringiensis | |
MX2011006685A (es) | Inhibidores de metaloproteinas de matriz de membrana tipo-1 y sus usos. | |
AR073237A1 (es) | Proteinas de bacillus thuringiensis que son toxinas activas contra hemipteros y coleopteros | |
PE20140190A1 (es) | Moduladores de proteinas notum y metodos de uso | |
NO20082510L (no) | En fremgangsmate for konsentrasjon av et polypeptid | |
PE20181054A1 (es) | Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion | |
RS52537B (en) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR ANEMIA TREATMENT | |
AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
EA201491049A1 (ru) | Противораковый слитый белок | |
EA201390820A1 (ru) | Слитый белок против рака | |
SG178797A1 (en) | Oligosaccharide chain added glp-1 peptide | |
NI201200134A (es) | Polipéptidos agonistas que se enlazan a dr5 | |
PE20130199A1 (es) | Proteina de fusion robo1-fc y su utilizacion en el tratamiento de tumores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |